WS

Weiying Sarah Wang

Director Director DIN 08369289
DIN 08369289 First appointment Mar 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2019
Shareholding value Locked Premium profile

About Weiying Sarah Wang

Data last updated:

Weiying Sarah Wang has 7 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08369289
Primary Designation Director
First Appointment 13 Mar 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Astrazeneca Pharma India Limited L24231KA1979PLC003563
Director13 Mar 20191979Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astrazeneca Pharma India Limited
Premium access

Shareholding and investment profile for Weiying Sarah Wang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Weiying Sarah Wang

Weiying Sarah Wang has 7 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

Weiying Sarah Wang is associated with 0 companies as a director.

Weiying Sarah Wang has expertise in General Business.

Weiying Sarah Wang has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available